Proteomic characterization of Toxoplasma gondii ME49 derived strains resistant to the artemisinin derivatives artemiside and artemisone implies potential mode of action independent of ROS formation.

Apicomplexan parasites Drug resistance Mass spectrometry Model organism Reactive oxygen species Untargeted proteomics

Journal

International journal for parasitology. Drugs and drug resistance
ISSN: 2211-3207
Titre abrégé: Int J Parasitol Drugs Drug Resist
Pays: Netherlands
ID NLM: 101576715

Informations de publication

Date de publication:
04 2023
Historique:
received: 21 09 2022
revised: 26 11 2022
accepted: 28 11 2022
medline: 4 4 2023
pubmed: 14 12 2022
entrez: 13 12 2022
Statut: ppublish

Résumé

The sesquiterpene lactone artemisinin and its amino-artemisinin derivatives artemiside (GC008) and artemisone (GC003) are potent antimalarials. The mode of action of artemisinins against Plasmodium sp is popularly ascribed to 'activation' of the peroxide group by heme-Fe(II) or labile Fe(II) to generate C-radicals that alkylate parasite proteins. An alternative postulate is that artemisinins elicit formation of reactive oxygen species by interfering with flavin disulfide reductases resposible for maintaining intraparasitic redox homeostasis. However, in contradistinction to the heme-activation mechanism, the amino-artemisinins are effective in vitro against non-heme-degrading apicomplexan parasites including T. gondii, with IC

Identifiants

pubmed: 36512904
pii: S2211-3207(22)00032-X
doi: 10.1016/j.ijpddr.2022.11.005
pmc: PMC9763631
pii:
doi:

Substances chimiques

artemisone 796LMW5BUZ
Reactive Oxygen Species 0
Antimalarials 0
Ferrous Compounds 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-12

Informations de copyright

Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Auteurs

Joachim Müller (J)

Institute of Parasitology, University of Bern, Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, Länggass-Strasse 122, CH-3012, Bern, Switzerland.

Carling Schlange (C)

Institute of Parasitology, University of Bern, Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, Länggass-Strasse 122, CH-3012, Bern, Switzerland.

Manfred Heller (M)

Proteomics & Mass Spectrometry Core Facility, Department for BioMedical Research (DBMR), University of Bern, Freiburgstrasse 15, CH-3010, Bern, Switzerland.

Anne-Christine Uldry (AC)

Proteomics & Mass Spectrometry Core Facility, Department for BioMedical Research (DBMR), University of Bern, Freiburgstrasse 15, CH-3010, Bern, Switzerland.

Sophie Braga-Lagache (S)

Proteomics & Mass Spectrometry Core Facility, Department for BioMedical Research (DBMR), University of Bern, Freiburgstrasse 15, CH-3010, Bern, Switzerland.

Richard K Haynes (RK)

Centre of Excellence for Pharmaceutical Sciences, Faculty of Health Sciences, North-West University, Potchefstroom, 2520, South Africa.

Andrew Hemphill (A)

Institute of Parasitology, University of Bern, Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, Länggass-Strasse 122, CH-3012, Bern, Switzerland. Electronic address: andrew.hemphill@vetsuisse.unibe.ch.

Articles similaires

Biofilms Candida albicans Quorum Sensing Candida glabrata Menthol
Humans Female Pregnancy Adult Cameroon
Humans Arthritis, Rheumatoid Lipid Metabolism Male Female

Classifications MeSH